Todor Arsov

1.9k total citations
41 papers, 1.1k citations indexed

About

Todor Arsov is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Todor Arsov has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Todor Arsov's work include Genomics and Rare Diseases (7 papers), Diet and metabolism studies (5 papers) and Metabolism and Genetic Disorders (4 papers). Todor Arsov is often cited by papers focused on Genomics and Rare Diseases (7 papers), Diet and metabolism studies (5 papers) and Metabolism and Genetic Disorders (4 papers). Todor Arsov collaborates with scholars based in Australia, North Macedonia and Croatia. Todor Arsov's co-authors include Мирко Спироски, Ingrid E. Scheffer, Samuel F. Berkovic, John A. Damiano, Александар Петличковски, Ana Strezova, Дејан Трајков, Christopher C. Goodnow, Nikolai Petrovsky and Saul A. Mullen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Todor Arsov

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todor Arsov Australia 18 340 255 253 226 220 41 1.1k
Dominique Bozon France 23 232 0.7× 745 2.9× 84 0.3× 295 1.3× 217 1.0× 57 2.4k
Francesca Menni Italy 17 162 0.5× 271 1.1× 45 0.2× 208 0.9× 115 0.5× 46 1.0k
P Madoz Spain 18 95 0.3× 146 0.6× 99 0.4× 49 0.2× 382 1.7× 48 1.2k
Yoshiyuki Ohtomo Japan 21 175 0.5× 360 1.4× 40 0.2× 94 0.4× 97 0.4× 91 1.5k
Patrizia Accorsi Italy 21 290 0.9× 266 1.0× 134 0.5× 48 0.2× 83 0.4× 111 1.3k
Susanna Ranta Finland 20 183 0.5× 335 1.3× 70 0.3× 431 1.9× 124 0.6× 93 1.6k
Pranoot Tanpaiboon United States 18 186 0.5× 285 1.1× 44 0.2× 329 1.5× 110 0.5× 55 820
Adel Shalata Israel 15 212 0.6× 706 2.8× 32 0.1× 88 0.4× 154 0.7× 42 1.2k
Isabelle Fajardy France 20 320 0.9× 301 1.2× 18 0.1× 153 0.7× 148 0.7× 44 1.5k
A Piazza Italy 17 93 0.3× 314 1.2× 72 0.3× 54 0.2× 111 0.5× 70 1.0k

Countries citing papers authored by Todor Arsov

Since Specialization
Citations

This map shows the geographic impact of Todor Arsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todor Arsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todor Arsov more than expected).

Fields of papers citing papers by Todor Arsov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todor Arsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todor Arsov. The network helps show where Todor Arsov may publish in the future.

Co-authorship network of co-authors of Todor Arsov

This figure shows the co-authorship network connecting the top 25 collaborators of Todor Arsov. A scholar is included among the top collaborators of Todor Arsov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todor Arsov. Todor Arsov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tasić, Velibor, et al.. (2025). Nephrotic Syndrome Induced by Tiopronin in a Male Patient with Cystinuria. Balkan Journal of Medical Genetics. 28(1). 20250012–20250012.
2.
Devery, Sophie, et al.. (2025). Endocrinologist-led genomic testing for monogenic diabetes in adult diabetes clinics: a feasibility and outcome study. Diabetes Research and Clinical Practice. 229. 112456–112456.
3.
Zhou, Haibo, Vicki Athanasopoulos, Qian Shen, et al.. (2023). De Novo PACSIN1 Gene Variant Found in Childhood Lupus and a Role for PACSIN1/TRAF4 Complex in Toll‐like Receptor 7 Activation. Arthritis & Rheumatology. 75(6). 1058–1071. 11 indexed citations
5.
Šestan, Mario, Todor Arsov, Matthew Cook, et al.. (2023). The Role of Genetic Risk Factors in Pathogenesis of Childhood-Onset Systemic Lupus Erythematosus. Current Issues in Molecular Biology. 45(7). 5981–6002. 8 indexed citations
7.
Arsov, Todor, et al.. (2022). Semilobar Holoprosencephaly Caused by a Novel and De NovoZIC2Pathogenic Variant. SHILAP Revista de lepidopterología. 25(2). 71–76. 1 indexed citations
8.
Arsov, Todor, et al.. (2021). Expanding the clinical spectrum of pathogenic variation in NR2F2: Asplenia. European Journal of Medical Genetics. 64(12). 104347–104347. 3 indexed citations
9.
Arsov, Todor, et al.. (2019). Genomic test ends a long diagnostic odyssey in a patient with resistance to thyroid hormones. Thyroid Research. 12(1). 7–7. 1 indexed citations
10.
Arsov, Todor, Mario Šestan, Yuke He, et al.. (2018). Systemic lupus erythematosus: A new autoimmune disorder in Kabuki syndrome. European Journal of Medical Genetics. 62(6). 103538–103538. 7 indexed citations
11.
Kivity, Sara, Karen Oliver, Zaid Afawi, et al.. (2017). SCN1A clinical spectrum includes the self-limited focal epilepsies of childhood. Epilepsy Research. 131. 9–14. 16 indexed citations
12.
Damiano, John A., Saul A. Mullen, Michael S. Hildebrand, et al.. (2015). Evaluation of multiple putative risk alleles within the 15q13.3 region for genetic generalized epilepsy. Epilepsy Research. 117. 70–73. 5 indexed citations
13.
Harvey, A. Simon, Xenia Iona, Leanne M. Dibbens, et al.. (2012). Febrile infection-related epilepsy syndrome is not caused by SCN1A mutations. Epilepsy Research. 100(1-2). 194–198. 10 indexed citations
14.
Arsov, Todor, Saul A. Mullen, John A. Damiano, et al.. (2012). Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia. 53(12). e204–7. 83 indexed citations
15.
Arsov, Todor, Saul A. Mullen, A. Marie Phillips, et al.. (2012). Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Annals of Neurology. 72(5). 807–815. 103 indexed citations
16.
Mullen, Saul A., Carla Marini, Arvid Suls, et al.. (2011). Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy. Archives of Neurology. 68(9). 1152–1152. 91 indexed citations
17.
Anand, Geetha, Donncha Hanrahan, Hans Scheffer, et al.. (2011). Milder phenotypes of glucose transporter type 1 deficiency syndrome. Developmental Medicine & Child Neurology. 53(7). 664–668. 14 indexed citations
18.
Spiroski, Igor, Slobodan Antov, Todor Arsov, et al.. (2008). Association of Methylenetetrahydrofolate Reductase (MTHFR-677 and MTHFR-1298) Genetic Polymorphisms with Occlusive Artery Disease and Deep Venous Thrombosis in Macedonians. Croatian Medical Journal. 49(1). 39–49. 27 indexed citations
19.
Петличковски, Александар, et al.. (2006). Gene frequencies of human platelet antigens in the Macedonian population. Tissue Antigens. 67(3). 241–246. 9 indexed citations
20.
Петличковски, Александар, et al.. (2003). Influence of the elevated ambient temperature on immunoglobulin G and immunoglobulin G subclasses in sera of Wistar rats. Vojnosanitetski pregled. 60(6). 657–661. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026